Design and Synthesis of Highly Selective, Orally Active Polo-like Kinase-2 (Plk-2) Inhibitors.
Simeon Bowers,Anh P. Truong,Michael Ye,Danielle L. Aubele,Jennifer M. Sealy,R. Jeffrey Neitz,Roy K. Hom,Wayman Chan,Michael S. Dappen,Robert A. Galemmo,Andrei W. Konradi,Hing L. Sham,Yong L. Zhu,Paul Beroza,George Tonn,Heather Zhang,Jennifer Hoffman,Ruth Motter,Donald Fauss,Pearl Tanaka,Michael P. Bova,Zhao Ren,Danny Tam,Lany Ruslim,Jeanne Baker, Deepal Pandya,Linnea Diep,Kent Fitzgerald,Dean R. Artis,John P. Anderson,Marcelle Bergeron Bioorganic & Medicinal Chemistry Letters（2013）
关键词
Polo like kinase,PLK inhibitor,Parkinson's disease,Alpha-synuclein
AI 理解论文
溯源树
样例
